Life Science

Sogeti Ireland launches new Life Sciences practice

In today’s new world, our health has become our priority. Indeed, the adage ‘your health is your wealth’ has never been so relevant.

There is a weight of expectation on the life sciences sectors to help deliver on that priority. But they can’t do it alone. How can technology organizations like Sogeti Ireland be part of the transformation needed to make this happen?

Collaboration in intelligent industry

A recent study by the Capgemini Research Institute reveals that compared to two years ago, more organizations are progressing with smart factory initiatives today and one-third of factories have already been transformed into smart facilities, with plans to make 40% more smart factories in the next five years. Organizations are focusing on both efficiency by design and achieving operational excellence through closed-loop operations.

The report points out several reasons for this uptake: higher penetration of smart factory initiatives, aggressive plans by organizations, and an increase in expected benefits. These benefits could be seen not just in productivity improvements but also in accelerated product-portfolio rotation and faster time to market which will further translate into an increased market share.

Sogeti Ireland, part of the Capgemini Group, is launching a dedicated Life Sciences practice in Ireland, that will bring together the best of what Capgemini and Altran, it’s recently acquired engineering and R&D business, can offer in support of Ireland’s Life Science ecosystem.

According to Xavier de Bustos, head of Sogeti Ireland’s new dedicated Life Sciences practice: “Life Science is an important sector for the Irish economy and employment, as well as for the world, post COVID-19. Pharmaceutical and Medical Device organizations face many challenges in areas such as digitalization, regulation and compliance, supply chain, and R&D and I’m really excited to be leading a team who can help those organisations deal with those challenges.”

Sogeti Ireland’s Life Science practice brings strength and depth in supporting the industry’s digital transformation with smart factory, digital twin, virtual commissioning, AR/VR, and predictive analytics. It will also focus on regulatory affairs and quality assurance and compliance: CSV, validations, etc, including the new Medical Device Regulations (MDR) and In-Vitro Diagnostic Regulations (IVDR). In addition, Sogeti Ireland will offer significant expertise in patient centric product innovation, development, and IT healthcare services, such as digital therapeutics, connected health and software as a medical device (SAMD). 

Confronting the Smart Factory Challenge

Life Science organizations need to confront the next challenge of scaling smart factory initiatives. Organizations realize that success is hard to come by, with many characterizing their existing initiatives as not successful. The main issues identified with achieving scale, are challenges with IT-OT convergence and the need to develop “hybrid” capabilities and soft skills. Sogeti Ireland aim to provide end-to-end assistance to Life Science organisations on the smart factory journey.

For Sogeti Ireland, there is now a great opportunity to be part of this rapidly transforming industry. According to its Country Head James Govan, the dedicated Life Sciences practice has the potential to create more than 50 jobs in Ireland over the next three years as it offers increasingly sophisticated ‘Intelligent Industry’ solutions, technologies and processes.

To learn more about Sogeti Ireland’s dedicated Life Sciences practice, contact

  • Rory O'Connor
    Rory O'Connor
    Head of Practice
    +353 873497127
Sogeti Ireland Twitter
Print Email